SLU-PP-332 is an experimental small molecule, not a peptide, designed in the laboratory to switch on estrogen-related receptor alpha (ERR-alpha), a regulator of how muscle cells burn fuel. Because activating this pathway reproduces some of the genetic signals that exercise itself triggers, researchers describe SLU-PP-332 as an "exercise mimetic" and have studied it for endurance, fat oxidation, and metabolic health. It is important to be clear at the outset: the evidence is early and entirely preclinical. SLU-PP-332 has been tested only in cell and animal models, with no published human trials and no human safety data. It is not FDA approved, not approved by any major regulator, and is classified internationally as a research-use-only compound. The Menscape Clinic team in Bangkok provides this page for education only. SLU-PP-332 is not part of our prescribed treatment menu.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Weight-Loss Management
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
SLU-PP-332 is a synthetic small-molecule compound first reported by researchers at Saint Louis University School of Medicine. Despite often being grouped with peptides by online vendors, it is not a peptide. It is a designed chemical that acts as an agonist of the estrogen-related receptors (ERR-alpha, ERR-beta, and ERR-gamma), with the strongest action at ERR-alpha. These receptors help control the genes that govern how cells produce and burn energy. Interest in SLU-PP-332 comes from animal experiments suggesting it can mimic some of the metabolic signals normally produced by physical exercise. The crucial context for any reader is that all of this evidence is preclinical. SLU-PP-332 has been studied in cells and in mice, and there are no published human clinical trials. At Menscape Clinic in Bangkok, we believe a premium men's-health service means being honest about how early this science is.
/)
In cells, ERR-alpha sits at the centre of the network that drives mitochondrial biogenesis, fatty-acid oxidation, and energy expenditure. When you exercise, your muscles naturally increase ERR-alpha activity, which is part of how training improves endurance and metabolism over time. SLU-PP-332 is designed to activate this same receptor pharmacologically. In sedentary mice, it produced a gene-expression pattern resembling an acute aerobic exercise response and improved running endurance. Researchers therefore describe it as an exercise mimetic. It is essential to understand the limits of this idea: mimicking a gene signature in mouse muscle is not the same as safely reproducing the benefits of exercise in a human being, and that leap has not been demonstrated.
/)
To date, SLU-PP-332 has been investigated in laboratory cell systems and in rodent models, including studies of endurance, obesity, metabolic syndrome, heart-failure, and aging-kidney inflammation. As of mid-2026, there is no registered or completed human clinical trial, no published human pharmacokinetic or safety data, and no IND or regulatory submission for any human use. This means there is no established human dose, no defined safety profile in people, and no evidence base to identify who, if anyone, might appropriately use it. For this reason it cannot responsibly be framed as a treatment for any group of patients.
/)
Menscape Clinic in Bangkok is a premium men's-health practice serving both local and international, English-speaking patients. We are sometimes asked about SLU-PP-332 because it circulates online as an exercise-in-a-bottle or weight-loss compound. Our position is straightforward: because SLU-PP-332 has no human data, no regulatory approval, and is sold only as a research-use-only chemical, we do not prescribe, compound, or supply it, and we do not offer it as part of any program. What we do offer is an evidence-based weight-management and metabolic-health assessment, where a doctor reviews your goals and recommends options that carry genuine human evidence and a defined safety profile. If you have seen SLU-PP-332 marketed and want to understand it, our team is happy to talk you through the science.
/)
Any conversation about SLU-PP-332 starts with a physician explaining what the research does and does not yet show — never a sales pitch.
We do not sell SLU-PP-332 over the counter or source it from unregulated suppliers, and it is never handed out on request.
Because human safety data is limited or absent, we say so plainly rather than imply a proven or routine treatment.
We treat SLU-PP-332 as an experimental, research-stage compound — not a standard program we market or promote.
No. SLU-PP-332 is not approved by the FDA, the EMA, or any other major regulator for any human use, and there is no IND on file. It is classified as a research-use-only tool compound, sold for laboratory research and labelled not for human consumption. It is not available through legitimate prescription or compounding-pharmacy channels. Products marketed online for personal use sit in a legal grey area and are not quality-controlled medicines.
There is no human safety data for SLU-PP-332. No phase 1 trial has been conducted and no human side-effect profile exists, so its risks in people are genuinely unknown. Activating ERR receptors affects core energy and metabolic pathways throughout the body, which is precisely why an unstudied compound acting on them warrants caution. Menscape Clinic does not consider it safe to recommend, and we do not provide it.
No, although it is frequently mislabelled as one. SLU-PP-332 is a synthetic small-molecule drug-like compound, not a chain of amino acids. The confusion comes from it being sold alongside research peptides by the same online suppliers.
There is no evidence that it does in humans. The exercise-mimetic label comes from mouse studies showing it can switch on an exercise-like gene program in muscle and improve rodent endurance. Reproducing a gene signature in animals is a long way from safely delivering the full benefits of exercise in a person, and that has not been shown.
No. Because SLU-PP-332 has no human evidence, no regulatory approval, and exists only as a research chemical, we do not prescribe, compound, or supply it. We can, however, offer a doctor-led weight-management and metabolic-health consultation focused on options with real human evidence.
Rather than experimental compounds, our doctors focus on assessment and treatments with established human evidence and clear regulatory status, alongside nutrition, training, and lifestyle support tailored to men. During a consultation in Bangkok we can review what is appropriate and safe for your individual health profile.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)